<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7225641\results\search\tropicalVirus\results.xml">
  <result pre="the clinical samples was used to identify the circulating arboviruses." exact="Dengue" post="virus (DENV)-positive samples were further characterized by amplifying and"/>
  <result pre="the envelope gene. Results The overall prevalence rates of DENV," exact="Zika" post="virus, and chikungunya virus were 83.4%, 7.6%, and 0.9%,"/>
  <result pre="the clinical samples collected in April 2016 were as follows:" exact="DENV" post="39.6%, Zika virus 16.7%, and chikungunya virus 6.3%, which"/>
  <result pre="samples collected in April 2016 were as follows: DENV 39.6%," exact="Zika" post="virus 16.7%, and chikungunya virus 6.3%, which increased to"/>
  <result pre="December 2016. The displacement of the circulating serotype-3, genotype-1, with" exact="DENV" post="serotype 2, genotype cosmopolitan was responsible for the outbreak"/>
  <result pre="cosmopolitan was responsible for the outbreak in 2016. Conclusions A" exact="DENV" post="outbreak in Solomon Islands was caused by the introduction"/>
  <result pre="the introduction of a single serotype. The high prevalence of" exact="DENV" post="provided transient cross-protection, which prevented the introduction of a"/>
  <result pre="molecular tools, increase regional communication, and perform timely interventions. Keywords" exact="Dengue" post="fever Arbovirus Seroprevalence Molecular Immunity Funding http://dx.doi.org/10.13039/501100012412Kansai Medical University"/>
  <result pre="Molecular Immunity Funding http://dx.doi.org/10.13039/501100012412Kansai Medical University grant D2DarcyAndrew Waleluma Introduction" exact="Dengue" post="fever (DF) is the most prevalent mosquito-borne viral infection"/>
  <result pre="can lead to severe organ complications and even death [2–4]." exact="Dengue" post="virus (DENV) is a Flavivirus from the Flaviviridae family."/>
  <result pre="[8]. On the other hand, in SE Asia all four" exact="DENV" post="serotypes are circulating, and a 3-year wave-like outbreak pattern,"/>
  <result pre="in addition to the global expansion and reported occurrence of" exact="Zika" post="virus (ZIKV) and chikungunya virus (CHKV) infections in the"/>
  <result pre="commercial IgM ELISA kits (ZIKV IgM ELISA, MyBioSource Inc., and" exact="CHIKV" post="IgM ELISA, Abcam). Molecular testing The qPCR screening was"/>
  <result pre="for various molecular tests. The qPCR screening used previously described" exact="DENV" post="serotype-specific and ZIKV-specific primers (Table 1) with some modifications"/>
  <result pre="AAG AAA AT CAG CAT TAT CCGGTA CTC CAG AT" exact="CHIKV" post="CAA GAA AAT AAC ATC ACT GTA ACT TCC"/>
  <result pre="ATC ACT GTA ACT TCC AGG CTG AAG ACA TTG" exact="DENV" post="envelope gene sequencing and phylogenetic tree analysis The DENV"/>
  <result pre="TTG DENV envelope gene sequencing and phylogenetic tree analysis The" exact="DENV" post="envelope genes were investigated using cDNA templates from patients"/>
  <result pre="templates from patients that were found to be positive for" exact="DENV" post="in the clinical surveys conducted in Gizo and Honiara."/>
  <result pre="83.4% (95% CI 77.7–88.3%) (Table 2). The prevalence of the" exact="DENV" post="was slightly higher in Honiara (88.4%) than in Gizo"/>
  <result pre="was not significant (p = 0.14). The prevalence of the" exact="DENV" post="differed significantly between females (88.6%) and males (77.1%) (p"/>
  <result pre="affected the prevalence of the DENV. The prevalence of the" exact="DENV" post="increased with age, with the lowest prevalence rate (61.5%)"/>
  <result pre="was defined as the annual risk of infection by any" exact="DENV" post="serotype among DENV-naïve individuals, was 16.4% in the 1–20 years"/>
  <result pre="172 13 (7.6) (4.1–11.6)  Chikungunya 122 1 (0.9) (0.0–8.6) B." exact="Dengue" post="prevalence Site   Gizo 110 88 (80.0) (71.3–87.0) 0.14   Honiara"/>
  <result pre="103 0.17 (0.135–0.231) 0.00 Fig. 3 The prevalence of the" exact="DENV" post="in different age groups in the household survey The"/>
  <result pre="prevalence results for the other arboviruses were 7.6% for the" exact="ZIKV" post="and 0.9% for the CHKV (Table 2). Clinical survey"/>
  <result pre="positivity rate for anti-DENV IgG antibodies (77.9%) and the high" exact="DENV" post="positivity rate detected in the qPCR analysis of the"/>
  <result pre="48 samples tested in April 2016, all of the detected" exact="DENV" post="belonged to the DENV-3 serotype. In December, however, the"/>
  <result pre="5 samples were co-infected with the DENV-3 serotype. The qPCR-based" exact="ZIKV" post="detection rate was 16.7% in April, and it increased"/>
  <result pre="34 DENV-negative samples. Sensitivity and specificity of the RDT for" exact="DENV" post="Among the clinical samples collected in December, a subset"/>
  <result pre="was used to calculate the sensitivity and specificity of the" exact="DENV" post="RDT compared with the qPCR reference test (Table 3)."/>
  <result pre="compared with the qPCR reference test (Table 3). Table 3" exact="Dengue" post="RDT sensitivity and specificity on 109 clinical samples Dengue"/>
  <result pre="3 Dengue RDT sensitivity and specificity on 109 clinical samples" exact="Dengue" post="assay Sensitivity Specificity PPV NPV RDT NS1 49/82 (60%)"/>
  <result pre="IgG 26/82 (46%) 13/26 (50%) 26/39 (67%) 13/69 (19%) The" exact="DENV" post="RDT combo kit included tests for NS1, IgM, and"/>
  <result pre="suggested was indicative of a high rate of secondary infections." exact="DENV" post="envelope gene phylogenetic analysis Dengue virus serotype 3 The"/>
  <result pre="high rate of secondary infections. DENV envelope gene phylogenetic analysis" exact="Dengue" post="virus serotype 3 The phylogenetic tree for DENV-3 shown"/>
  <result pre="the Pacific region. Fig. 4 The evolutionary history of the" exact="DENV" post="according to an analysis of DENV-3 envelope gene (1479-bp)"/>
  <result pre="in April. The sequences in the tree were classed under" exact="DENV" post="serotype 3, genotype-1. The PICT lineage, which included isolates"/>
  <result pre="the evolution of DF and its introduction to the PICTs." exact="Dengue" post="virus serotype 2 The DENV-2 phylogenetic tree shown in"/>
  <result pre="obtained from GenBank. Fig. 5 The evolutionary history of the" exact="DENV" post="according to an analysis of DENV-2 envelope gene (1485-bp)"/>
  <result pre="previously circulating the Pacific region (1996–1999). Discussion The prevalence of" exact="DENV" post="in our study was comparable to those seen in"/>
  <result pre="studies conducted in the region. For example, the prevalence of" exact="DENV" post="was reported to be 95.6% in Samoa, 83% in"/>
  <result pre="suggested that such exposure induces 3 years transient cross-protection against other" exact="DENV" post="serotypes [29]. This would have provided herd immunity, which"/>
  <result pre="It was also suggested that DENV-immune individuals are cross-protected against" exact="ZIKV" post="[31], which would probably explain the low prevalence of"/>
  <result pre="ZIKV [31], which would probably explain the low prevalence of" exact="ZIKV" post="in April 2016 despite its circulation in the country"/>
  <result pre="country in 2015 (GenBank KX 216632) [32]. The high qPCR-based" exact="DENV" post="detection rate seen in our DENV-immune study population pointed"/>
  <result pre="in our DENV-immune study population pointed to a high secondary" exact="DENV" post="infection rate during the 2016 outbreak. Secondary infections involve"/>
  <result pre="infection rate during the 2016 outbreak. Secondary infections involve heterologous" exact="DENV" post="infections and are associated with an increased risk of"/>
  <result pre="with an increased risk of severe DF [33, 34]. The" exact="DENV" post="responsible for the new infection will trigger antibody production"/>
  <result pre="which is linked with severe DF. The use of NS1-based" exact="DENV" post="RDT in a resource-poor setting was very useful for"/>
  <result pre="previous DENV-3 outbreak in 2013 [36]. Secondary infections and the" exact="DENV" post="serotype are important factors affecting the diagnostic sensitivity of"/>
  <result pre="molecular sequencing analysis to identify genotype and subgenotype lineages. The" exact="DENV" post="has probably been introduced into the PICTs multiple times"/>
  <result pre="molecular surveillance in PNG will enable more accurate prediction of" exact="DENV" post="outbreaks in the Pacific region. Recent improvements in airline"/>
  <result pre="study was initially designed to explore the population’s immunity to" exact="DENV" post="in order to predict its outbreak potential. The sample"/>
  <result pre="size was small, as it was based on the high" exact="DENV" post="positivity rate (approximately 30%) seen during the last outbreak."/>
  <result pre="last outbreak. It was therefore not ideal for investigating the" exact="ZIKV" post="or CHKV, which have low prevalence rates. As the"/>
  <result pre="of the 2016 DLI outbreak, but there was evidence of" exact="ZIKV" post="and CHKV co-circulating. The outbreak pattern suggests that natural"/>
  <result pre="best as they can for the next outbreak. Abbreviations DF" exact="Dengue" post="fever DLI Dengue-like illness ELISA Enzyme-linked immunosorbent assays DENV"/>
  <result pre="DF Dengue fever DLI Dengue-like illness ELISA Enzyme-linked immunosorbent assays" exact="DENV" post="Dengue virus PICTs Pacific Island countries SE Asia Southeast"/>
  <result pre="Dengue fever DLI Dengue-like illness ELISA Enzyme-linked immunosorbent assays DENV" exact="Dengue" post="virus PICTs Pacific Island countries SE Asia Southeast Asia"/>
  <result pre="virus PICTs Pacific Island countries SE Asia Southeast Asia CHKV" exact="Chikungunya" post="virus ZIKV Zika virus EDTA Ethylenediaminetetraacetic acid RDT Rapid"/>
  <result pre="Pacific Island countries SE Asia Southeast Asia CHKV Chikungunya virus" exact="ZIKV" post="Zika virus EDTA Ethylenediaminetetraacetic acid RDT Rapid diagnostic test"/>
  <result pre="Island countries SE Asia Southeast Asia CHKV Chikungunya virus ZIKV" exact="Zika" post="virus EDTA Ethylenediaminetetraacetic acid RDT Rapid diagnostic test PNG"/>
  <result pre="Australia, 2014PLoS Curr201426 19.CormanVMRascheABarontiCAldabbaghSCadarDReuskenCBet al.Assay optimization for molecular detection of" exact="Zika" post="virusBull World Health Organ2016941288089210.2471/BLT.16.17595027994281 20.PhommanivongVKandaSShimonoTLamaningaoPDarcyAWMishimaNet al.Co-circulation of the dengue"/>
  <result pre="Zika: a pediatric cohort in NicaraguaPLoS Med2019161e100272610.1371/journal.pmed.100272630668565 32.PykeATMoorePRHall-MendelinSMcMahonJLHarrowerBJConstantinoTRet al.Isolation of" exact="Zika" post="virus imported from Tonga into AustraliaPLoS Curr201678 33.GuzmanMGAlvarezMHalsteadSBSecondary infection"/>
 </snippets>
</snippetsTree>
